Miles White

Type: Person
Name: Miles White (Miles D. White)
Title: Chairman and chief executive officer
Organization: Abbott Laboratories
Date of Birth: 1955
Place of Birth: Minneapolis, Minnesota
Nationality: United States
Fact Sheet: Biography for Miles White
First reported Oct 27 2014 - Updated Oct 28 2014 - 1 reports

Abbott reports lower Q3 net earnings, provides outlook for 2014

Abbott, a healthcare company, has reported that net earnings for the third quarter ended September 30, 2014 were $538 million, or $0.36 per diluted share, compared to $966 million, or $0.61 per diluted share, for the same quarter ended September 30, 2013. ... [Published Individual.com - Oct 27 2014]
First reported Oct 27 2014 - Updated Oct 27 2014 - 1 reports

Emerging Markets Earnings: Abbott Laboratories Casts Fortune Abroad

Emerging markets now account for nearly half of Abbott Laboratories sales – a figure set to grow through regional focus and acquisitions, leading Chicago-based CEO Miles White and other executives to skip over vast portions of the globe in the third quarter ... [Published Health News Daily - Oct 27 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

Talk of the County: Readers take shots at ‘greedy’ teachers

Teaching momentIf Waukegan parents want their children back in school they need to realize that the teachers are as much the problem as the board members. They need to look at the teachers and their total lack of professional wisdom.For richer and po ... [Published Lake County News Sun - Oct 24 2014]
First reported Oct 22 2014 - Updated Oct 23 2014 - 1 reports

Abbott Laboratories' (ABT) CEO Miles White on Q3 2014 Results - Earnings Call Transcript

Related Biotechnology, Pharmaceutical and Healthcare NewsOriginal Article: NEXT ARTICLE More From BioPortfolio on "Abbott Laboratories' (ABT) CEO Miles White on Q3 2014 Results - Earnings Call Transcript" Search BioPortfolio:Loading ... [Published BioPortfolio - Oct 22 2014]
First reported Oct 22 2014 - Updated Oct 23 2014 - 4 reports

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

Shares of US health care company Abbott Laboratories (NYSE: ABT) rose slightly in the premarket trading period following reports that it had achieved better-than-expected profit for the third quarter. It attributed this success to improved performance ... [Published Pharma Letter - Oct 23 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

AbbVie CEO Gonzales loses Shire, but wins praise for gusty move

AbbVie (ABBV.N) Chief Executive Officer Richard Gonzalez for three months led the charge to buy Dublin drugmaker Shire for $55 billion (34.03 billion pounds), only to walk away from the deal last week, but analysts and fund managers said he deserves credit ... [Published Yahoo! Finance UK and Ireland - Oct 21 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Fall tailgating

Football season in Louisiana is as much about the camaraderie and the tailgating activities on game day as it is about the football game itself.The pre-game party is the perfect opportunity for sports-loving chefs to show-off their grill skills or impress ... [Published Daily Iberian - Oct 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Abbott Labs Gets No Respect Despite a Healthy Second Quarter

NEW YORK (TheStreet) --Abbott Laboratories is the proverbial diamond in the rough. It's a healthy company that recently sold its overseas generic pharmaceuticals business to Mylan Laboratories for $5.3 billion and then pleased investors with its second-quarter ... [Published The Street Latest - Jul 16 2014]
First reported May 19 2014 - Updated May 19 2014 - 1 reports

Abbott buys CFR Pharmaceuticals for US$2.9bn

CFR researches and produces off-patent and locally unpatented drugs19/05/2014 Will double branded generics salesHelen TunnicliffeUS PHARMACEUTICALS company Abbott Laboratories has bought Latin American generics pharmaceutical company CFR Pharmaceuticals ... [Published TCE Today - May 19 2014]

Quotes

"we reported another quarter of sequential sales growth, including improved performance in our branded generics pharmaceuticals and nutrition businesses, and we are particularly pleased with the growth in our vision care business" said Miles White, chairman and CEO, Abbott
"I have no intention of being out of the business, I have no intentions of shrinking," White said. "i have no intentions other than full steam ahead."
Abbott chairman and CEO Miles White said: "mylan has the scale and breadth across critical distribution channels and a complementary portfolio that will quickly position this business for success. mylan also shares our commitment to patients and product quality."

More Content

All (17) | News (15) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Emerging Markets Earnings: Abbott Laboratories ... [Published Health News Daily - Oct 27 2014]
Abbott reports lower Q3 net earnings, provides ... [Published Individual.com - Oct 27 2014]
Talk of the County: Readers take shots at ‘gree... [Published Lake County News Sun - Oct 24 2014]
Abbott Laboratories (ABT) Earnings Report: Q3 2... [Published The Street Latest - Oct 23 2014]
Abbott raises midpoint of EPS guidance and sees... [Published Pharma Letter - Oct 23 2014]
Abbott Laboratories (ABT) Earnings Report: Q3 2... [Published ShoreLine Times - Oct 23 2014]
Abbott earnings tumble as costs offset better s... [Published BusinessWeek - Oct 22 2014]
Abbott Laboratories' (ABT) CEO Miles White on Q... [Published BioPortfolio - Oct 22 2014]
Abbott Laboratories' (ABT) CEO Miles White on Q... [Published Seeking Alpha - Oct 22 2014]
AbbVie CEO Gonzales loses Shire, but wins prais... [Published Today Online - Oct 21 2014]
AbbVie CEO Gonzales loses Shire, but wins prais... [Published Yahoo! Finance UK and Ireland - Oct 21 2014]
AbbVie CEO Gonzales loses Shire, but wins prais... [Published Reuters - Oct 21 2014]
Fall tailgating [Published Daily Iberian - Oct 16 2014]
Abbott Labs Gets No Respect Despite a Healthy S... [Published The Street Latest - Jul 16 2014]
Mylan to acquire non-US developed markets speci... [Published Pharmaceutical Technology - Jul 15 2014]
Abbott buys CFR Pharmaceuticals for US$2.9bn [Published TCE Today - May 19 2014]
Biography for Miles White [Published Able2Act - Feb 01 2006]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.